Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa

Goga, Ameena Ebrahim; Bekker, Linda‑Gail; Garrett, N.; Reddy, Tarylee; Yende-Zuma, Nonhlanhla; Fairall, Lara; Moultrie, Harry; Takalani, Azwidihwi; Trivella, Valentina; Faesen, Mark; Bailey, Veronique C.; Seocharan, Ishen; Gray, Glenda E.

UPSpace Home
→
Health Sciences
→
Paediatrics and Child Health
→
Research Articles (Paediatrics and Child Health)
→
View Item

dc.contributor.author	Goga, Ameena Ebrahim
dc.contributor.author	Bekker, Linda‑Gail
dc.contributor.author	Garrett, N.
dc.contributor.author	Reddy, Tarylee
dc.contributor.author	Yende-Zuma, Nonhlanhla
dc.contributor.author	Fairall, Lara
dc.contributor.author	Moultrie, Harry
dc.contributor.author	Takalani, Azwidihwi
dc.contributor.author	Trivella, Valentina
dc.contributor.author	Faesen, Mark
dc.contributor.author	Bailey, Veronique C.
dc.contributor.author	Seocharan, Ishen
dc.contributor.author	Gray, Glenda E.
dc.date.accessioned	2023-08-28T12:58:52Z
dc.date.available	2023-08-28T12:58:52Z
dc.date.issued	2022-07
dc.description.abstract	No abstract available.	en_US
dc.description.department	Paediatrics and Child Health	en_US
dc.description.librarian	hj2023	en_US
dc.description.uri	http://www.thelancet.com	en_US
dc.identifier.citation	Goga, A., Bekker, L.G., Garrett, N. et al. 2022, 'Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa', Lancet, vol. 400, art. 10348, pp. 269-271, doi : 10.1016/S0140-6736(22)01190-4.	en_US
dc.identifier.issn	0140-6736 (print)
dc.identifier.issn	1474-547X (online)
dc.identifier.other	10.1016/S0140-6736(22)01190-4
dc.identifier.uri	http://hdl.handle.net/2263/92088
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.rights	© 2022 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Lancet . Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Lancet, vol. 400, art. 10348, pp. 269-271, doi : 10.1016/S0140-6736(22)01190-4.	en_US
dc.subject	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)	en_US
dc.subject	Omicron	en_US
dc.subject	Delta	en_US
dc.subject	South Africa (SA)	en_US
dc.subject	Correspondence	en_US
dc.title	Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa	en_US
dc.type	Postprint Article	en_US